Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL326581 | 0.95 | MEN1 (0.33) | MEN1ALDH1A1LMNAMAPTHPGD | |
| SCHEMBL2335528 | 0.91 | — | — | |
| SCHEMBL6753050 | 0.86 | MEN1 (0.33) | MEN1ALDH1A1LMNAMAPTHPGD | |
| SCHEMBL15352193 | 0.81 | — | — | |
| SCHEMBL15352364 | 0.72 | — | — | |
| SCHEMBL15054055 | 0.70 | TSHR (0.56) | MEN1ALDH1A1LMNAMAPTHPGD | |
| Perchlorobenzene SCHEMBL26562 | 0.67 | ALDH1A1 (0.50) | MEN1ALDH1A1LMNAMAPTHPGD | |
| Perchlorobenzene SCHEMBL8872243 | 0.67 | ALDH1A1 (0.50) | MEN1ALDH1A1LMNAMAPTHPGD | |
| Perchlorobenzene SCHEMBL1330781 | 0.67 | ALDH1A1 (0.50) | MEN1ALDH1A1LMNAMAPTHPGD | |
| SCHEMBL1547847 | 0.65 | CYP3A4 (0.56) | MEN1ALDH1A1LMNAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543267-A1 | URETHANE RESIN USING POLYROTAXANE, AND POLISHING PAD | Tokuyama Corporation (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-20100240713-A1 | AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | XENON PHARMACEUTICALS INC. (CA) | 2010-09-23 | — | — | US | disclosed |
| US-4212996-A | USING AN IRON OR ALUMINUM MASKING (COMPLEXING) AGENT CONTAINING AMINOACETIC ACID GROUPS | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1980-07-15 | — | — | US | disclosed |
| US-4211730-A | HALOBROMOBENZYL ACRYLATE | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1980-07-08 | — | — | US | disclosed |
| US-4128709-A | Acrylate-based polymers and their use as flameproofing agents | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1978-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240713-A1 | AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | SLC40A1, PAH, FECH | MEN1 933/4885ALDH1A1 749/4885LMNA 3426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.